Anatomy & Physiology › Section M · Somatic and autonomic nervous systems › Topic M.6

Central control and drugs affecting the ANS

Autonomic reflexes do not run on their own: the hypothalamus, the amygdala and the brainstem tune them to your emotions and activities. Many drugs work by imitating or blocking the chemicals at autonomic synapses, so knowing the receptors lets you predict what they do.

Higher control of autonomic reflexes

Visceral reflexes keep organs near their set points, but higher centres can shift or override them. The hypothalamus is the main integrating centre for autonomic function and also runs much of the endocrine system through the pituitary gland. It takes input from the limbic system and from sensors monitoring the blood, and sends output to brainstem nuclei and spinal preganglionic neurons. The medulla holds the centres that carry out cardiovascular and other visceral reflexes. Together they let emotion, exercise and temperature change autonomic output. This topic describes mechanisms for study only, not guidance on any treatment.

The hypothalamus

The hypothalamus lies below the thalamus, forming the floor and lower walls of the third ventricle. Limbic input reaches it from the amygdala through its own pathways and from the septal nuclei and olfactory cortex through the medial forebrain bundle, and it has its own sensors for blood temperature and osmolarity. Two tracts, that bundle and the dorsal longitudinal fasciculus, carry its output down to brainstem parasympathetic nuclei and the sympathetic lateral horn. Temperature is a good example: when blood is too warm, the hypothalamus relaxes skin vessels and drives sweating; when it is too cool, it constricts skin vessels and triggers shivering through somatic pathways.

The amygdala and emotion

The amygdala is a group of nuclei deep in the medial temporal lobe and part of the limbic system, which links emotion and memory. When it detects a threat, or recalls one, it signals the hypothalamus. The hypothalamus raises sympathetic output, producing the racing heart, sweating and dilated pupils of fear, and starts the release of stress hormones through the pituitary and adrenal glands. That is why an exam, a memory or a horror film can trigger fight-or-flight changes with no physical danger. Researchers now often describe threat responses as fight, flight or freeze, because some threats produce stillness rather than action.

Brainstem centres

The medulla contains the cardiovascular centre, which adjusts heart rate, contraction strength and vessel diameter. Blood pressure information arrives from nerves IX and X at the solitary nucleus. Vagal parasympathetic output comes from two nuclei: the nucleus ambiguus, a main source of cardiac slowing that also moves the throat and voice box muscles, and the vagus nerve's dorsal motor nucleus, which supplies the airways and gut. Sympathetic output descends to the lateral horn: upper thoracic preganglionic neurons drive the heart through the cardiac accelerator nerves, and neurons along T1 to L2 drive the vessels.

Worked example: a sudden fright

A loud bang in a quiet house makes your heart pound. Trace the control chain. 1. Sensation: the sound reaches the auditory pathway and, through fast routes, the amygdala, which flags a possible threat. 2. Hypothalamus: the amygdala signals the hypothalamus, which sends descending output to the brainstem and spinal cord. 3. Brainstem: vagal output to the heart falls. 4. Spinal cord: lateral horn neurons from T1 to about L2 fire, reaching the heart through chain ganglia and the adrenal medulla through splanchnic nerves. 5. Effectors: norepinephrine and circulating epinephrine speed the heart, dilate the pupils and start sweating. 6. Check: the response came from forebrain control, not from a change in blood pressure.

How drugs act on the ANS

A chemical made in the body, such as norepinephrine, is endogenous; one introduced from outside, from a plant or a laboratory, is exogenous. Most drugs that affect the ANS act at receptors. An agonist binds a receptor and activates it, mimicking the natural transmitter; an antagonist binds without activating, blocking the natural transmitter. Others change how much transmitter is released or how fast it is removed. Drugs are grouped by effect: sympathomimetic drugs mimic or enhance sympathetic signalling, sympatholytic drugs reduce it, parasympathomimetic drugs enhance cholinergic signalling at muscarinic receptors, and anticholinergic (parasympatholytic) drugs block it. The more selective a drug is for one receptor subtype, the narrower its effects.

Nicotine: stimulating every ganglion

Nicotine is an agonist at nicotinic receptors, so it activates ganglionic neurons of both divisions at once, and it also stimulates the chromaffin cells of the adrenal medulla. In many organs the two divisions then push in opposite directions and largely cancel. The cardiovascular system is the exception. Most blood vessels have sympathetic supply only, so their tone shifts towards constriction and blood pressure rises, helped by released epinephrine. The heart's pacemaker receives both speeding and slowing signals at once, which can disturb its rhythm. These mechanisms help explain why tobacco use is a recognised risk factor for cardiovascular disease.

Drugs at adrenergic receptors

Sympathomimetic drugs act at adrenergic synapses. Phenylephrine is an α₁ agonist: it contracts vascular smooth muscle, which narrows swollen vessels in the nasal lining and raises blood pressure, and as eye drops it contracts the radial dilator muscle, widening the pupil (mydriasis). Some stimulants, such as cocaine, block the reuptake of norepinephrine and dopamine, prolonging their action. Sympatholytic drugs block or damp sympathetic effects. Beta-blockers are β antagonists: blocking β₁ receptors slows the heart and weakens its contraction. Nonselective beta-blockers also block β₂ receptors, which can narrow the airways. Clonidine works indirectly, as an α₂ agonist in the brainstem that reduces sympathetic outflow.

Drugs at cholinergic synapses

Muscarinic agonists mimic parasympathetic effects; pilocarpine, for example, contracts the pupil's sphincter and constricts the pupil (miosis). Cholinesterase inhibitors block the enzyme that breaks down acetylcholine, so acetylcholine builds up at every cholinergic synapse, including neuromuscular junctions. Muscarinic antagonists such as atropine, from the deadly nightshade plant, block parasympathetic effects: the pupil dilates and cannot focus near objects, saliva and sweat dry up, gut movement slows and the heart speeds up as vagal slowing is removed. Because dosing and use are decisions for qualified prescribers, this course describes only how these drugs act.

Worked example: predicting drug effects

Predict each effect from the receptor alone. 1. Atropine on the heart: it blocks muscarinic receptors at the pacemaker, so vagal acetylcholine cannot slow it; with sympathetic input unchanged, heart rate rises. 2. A selective β₁ blocker on the airways: airway smooth muscle relaxes through β₂ receptors, which a selective β₁ blocker largely spares, so the airways change little, while heart rate falls. 3. Phenylephrine drops in the eye: α₁ receptors on the radial dilator muscle are activated, so the pupil dilates; the parasympathetic sphincter is unaffected. Check: in each case the effect follows from which receptor is activated or blocked, and in which tissue.

Common mistakes to avoid

First, assuming the autonomic system needs no brain input: the hypothalamus and medulla constantly tune it. Second, confusing agonists with antagonists: an agonist activates the receptor, an antagonist blocks it. Third, thinking nicotine acts only on sympathetic ganglia: it stimulates every autonomic ganglion. Fourth, linking beta-blockers with blood vessel constriction: β₁ receptors set heart rate and force, while α₁ receptors constrict vessels. Fifth, calling atropine a sympathetic drug: it blocks muscarinic receptors, and the faster heart reflects loss of vagal slowing. Sixth, assuming drug effects are confined to one organ: any tissue with the same receptor responds.

Key takeaways

The hypothalamus integrates autonomic control, receiving limbic input, sensing blood temperature and osmolarity, and projecting to brainstem nuclei and the lateral horn. The amygdala links emotion to sympathetic responses. The medulla's cardiovascular centre, solitary nucleus, nucleus ambiguus and dorsal motor nucleus of the vagus run cardiovascular reflexes. Agonists activate receptors and antagonists block them. Nicotine stimulates all ganglia, raising blood pressure. Phenylephrine is an α₁ agonist; beta-blockers block β receptors; clonidine is a central α₂ agonist. Muscarinic agonists mimic parasympathetic effects; atropine blocks them; cholinesterase inhibitors raise acetylcholine everywhere.

Flashcards

Flashcard

Hypothalamus

Main integrating centre for autonomic and much endocrine control

Projects to brainstem nuclei and the lateral horn.

Test your understanding

Question 1 of 5

Which structure is the main integrating centre that links emotion and blood sensors to autonomic output?

Question 2 of 5

Why does nicotine tend to raise blood pressure even though it stimulates both divisions of the ANS?

Question 3 of 5

A drug blocks muscarinic receptors throughout the body. Which effect is expected?

Question 4 of 5

Phenylephrine eye drops widen the pupil. Which mechanism explains this?

Question 5 of 5

A cholinesterase inhibitor is given. What happens at cholinergic synapses?

← Previous topicNext topic →